The Low DoseThe GLP-1 price desk
Briefing

Trimi vs Eden

$125/mo against $298/mo for tirzepatide. Which is worth it, and for whom.

Illustration of two objects on a balance scale

Updated 2026-09-18

Both sell tirzepatide. Trimi costs $125 a month and Eden costs $298, a difference of $173 a month or about $2,076 a year. The desk reads it as follows.

Trimi is lowest flat price with named pharmacies. Eden is low advertised medication price. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Trimi advertises $125 and bills $125; Eden advertises $199 and bills $298. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

TrimiEden
Advertised$125$199
Billed$125$298
Gapnone+$99
Per year, billed$1,500$3,576

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

2 differences on the record. The others match.

TrimiEden
Month-to-month without prepaying a blockNoYes
Names the compounding pharmacy publiclyYesNo

What each puts on the record: Trimi

  • One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
  • Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.

Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.

What each puts on the record: Eden

  • True ongoing cost for tirzepatide lands near $298/month once membership is included.

Where it wins: Genuinely low medication-only pricing. Watch for: The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.

In each one’s favour

Trimi.

  • The cheapest verified flat rate for compounded tirzepatide in this comparison.
  • Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.

Eden.

  • Genuinely low medication-only pricing.
  • Fast onboarding with flat rates across published dose ranges.

Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

The board says Trimi. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.

The verdict

On the board, Trimi at $125 a month is the more defensible choice on arithmetic alone. Eden earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and Eden.

How they sit against everyone else

ProgrammeAdvertisedBilledGapVs board floor
Coreage Rx$149$199+$50+$74/mo
Trimi$125$125none—
Ozari Health$125$125none—
Fifty 410$133$133none+$8/mo

More from the desk

  • Trimi tirzepatide review

    Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.

  • Eden tirzepatide review

    Advertised at $199, billed at $298. Position 11 of 18 on our board.

  • How to spot a bad seller

    The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

  • The twelve-month cost

    Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

  • Cheapest right now

    Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure